Advanced Cardiovascular Intervention 2009 Timings in PPCI: Have we learnt the lessons from our European Colleagues? Peter F Ludman.

Slides:



Advertisements
Similar presentations
EuroPa - Establishment of an European Network of Excellence Müller, M.(1), Neumann, H.(2), Jungraithmeier, T., Almann, F. J., Wagner, M., Smith, S. (1)
Advertisements

Patient Oriented Therapy for STE-MI
EXPERTS WORKSHOP ON EARLY TREATMENT STRATEGIES FOR ACUTE MYOCARDIAL INFARCTION FOR THE MIDDLE EAST COUNTRIES FEBRUARY 26 TH -28 TH 2005 / DUBAI, UAE SPONSORED.
Degli Studi e dei Registri: sul Territorio
Inequalities across Europe in access to primary angioplasty to treat acute heart attack patients -the cross-border dimension- John Martin, MD, FRCP, FESC,
A Pharmaco-invasive Reperfusion Strategy with Immediate Percutaneous Coronary Intervention is Safe and Effective in ST-Elevation Myocardial Infarction.
Regional AMI Care: Bridging the Rural Health Care Gap Darren B. Bean, MD University of Wisconsin Emergency Medicine/Medflight Director UW Level 1 Heart.
Optimal Timing of PCI in ACS Patrick Hildbrand. Trends and Prognosis in ACS Furman MI, JACC 2001, 37: Hospital 1 year.
Utilization of Rescue and Facilitated Angioplasty for Primary PCI: Who Should Get Lytic Therapy in 2009? Adnan Kastrati Deutsches Herzzentrum, Technische.
Treatmant patients with acute myocardial infarcton in Bosnia and Herzegovina BH Heart Centre Tuzla Terzić I, Čaluk J, Delić A, Osmanović E, Porović E,
PPCI – National Update NCBC Workshop Jim McLenachan, National Clinical Lead for PPCI, NHS Improvement, England. London, 24 th November, NCBC Annual.
Current and Future Perspectives on Acute Coronary Syndromes Paul W. Armstrong MD AMI Quebec Montreal October 1, 2010.
STEMI: What’s the Rush? STEMI: What’s the Rush? William Phillips, MD, FACC, FSCAI Director of Cardiology CMMC A PCI Center perspective.
Dallas 2015 TFQO: Karen Woolfrey COI #261 EVREV 1: Karen Woolfrey COI #261 EVREV 2: Daniel Pichel COI #513 Taskforce: ACS ACS 873: Pre-hospital STEMI Activation.
Perspective on COMMIT/CCS-2 Trial of Metoprolol in STEMI Christopher Cannon, M.D. Brigham and Women’s Hospital Boston, MA.
Improved Care for Acute Myocardial Infarction Linking Referral and Receiving Centres – How can We Communicate Better? Dr. James McMeekin AMI Faculty Cardiologist,
Primary PCI Treatment of choice for Acute MI.
GUSTO I GUSTO I Median Time (hrs) Between Symptom Onset and Treatment GUSTO III GUSTO III InTIME II InTIME II ASSENT.
Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health PCI in the UK: Fit for service? A view from the Department.
Interventional Registries The Audit and Research Potential of the BCIS CCAD Registry Peter F Ludman.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
GP IIb/IIIa Inhibition in STEMI: Growing Clinical Trial Evidence.
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
ACS and Thrombosis in the Emergency Setting
A modern thrombolysis service is superior to primary angioplasty
Ambulance Victoria and MonashHEART Acute Myocardial Infarction (Mon-AMI) 12 lead ECG project. An update On behalf of the MonAMI Team A Hutchison, Y Malaiapan,
Quality Standards for Patients Treated by PCI Peter F Ludman.
A H Gershlick University Hospital of Leicester UK A H Gershlick University Hospital of Leicester UK AA 2008 Who should we rescue ?
1 Primary Angioplasty for Acute STEMI Dr Adam Jacques Dr Sola Odemuyiwa February 2010.
Role of Percutaneous coronary intervention (PCI) after thrombolytic therapy By Dr. Mohamed Mahros Assistant lecturer of cardiology Benha faculty of medicine.
Primary Angioplasty – The case is not proven: pre-hospital thrombolysis with mandated PCI may be equally effective Primary Angioplasty – The case is not.
Management Of AMI Does time matter?? What is the best strategy: PPCI Vs TT.
To Transfer or Not to Transfer? The debate between transfer for PCI versus local thrombolysis. Todd Ring, BSc., MD, CCFP March 11, 2004 University of Calgary.
Patient Transfer Mark de Belder The James Cook University Hospital Middlesbrough.
Utilization of EMS Transport Among Patients with STEMI Findings from the National Cardiovascular Data ACTION Registry–Get With The Guidelines Robin Mathews,
National AMI Information Call February 5, 2008 Patient Safety Initiative.
What’s happened in 2007 and why? Mark de Belder President British Cardiovascular Intervention Society.
PPCI - it’s 24/7 or not at all? Dr JIM HALL CONSULTANT CARDIOLOGIST JAMES COOK UNIVERSITY HOSPITAL MIDDLESBROUGH.
Myocardial Ischaemia National Audit Project Are we replacing good fibrinolytic treatment with poor primary PCI? John Birkhead who has NO CONFLICT OF INTEREST.
Advanced Angioplasty 2005 Primary PCI making it happen Data collection and Timings Peter Ludman University Hospital Birmingham.
Glycoprotein IIb/IIIa inhibitors and bivalirudin: under utilised? Azfar Zaman Freeman Hospital Newcastle-upon-Tyne.
ReoPro ® in NSTEMI and STEMI Trials Harald Vangerow, MD Clinical Research Physician Eli Lilly UK.
Facilitated PCI: Use of Lytics in the ED Delayed PCI “The Rock Rokos” Lytics “Italian Stallion Hollander”
AA 2008 Session III: STEMI The UK data Mark de Belder The James Cook University Hospital Middlesbrough.
Lysis and Beyond: ESC Guidelines and Reality J N Townend Queen Elizabeth Hospital Birmingham.
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
Pharmacotherapy in acute coronary syndromes Perspective from first line and regional hospitals in Czech Republic Cardionale, Petr Jansky.
PCI for STEMI Ari de la Hera, M.D..
Inter-Hospital Transfer of High Risk STEMI Patients for PCI is Safe and Feasible David M. Larson, Katie M. Menssen, Scott W. Sharkey, Marc C. Newell, Anil.
Enoxaparin in primary PCI From FINESSE to ATOLL G. Montalescot Institut de Cardiologie Pitié-Salpêtrière Hospital Paris, France The FINESSE Trial is supported.
Managing AMI – much work still to do? MONDAY, 28 th FEBRUARY – SESSION 3 Patrick Goldstein EXPERTS WORKSHOP ON EARLY TREATMENT STRATEGIES FOR ACUTE MYOCARDIAL.
Door to Balloon Time: Does it Matter? Tale of Two Studies.
IABP用于高危PCI有价值吗? Is IABP Valuable for High-Risk PCI?
Size Matters Peter F Ludman MA MD FRCP University Hospital Birmingham.
Agrément FMC N° Conflits d’intérêt Astra-Zeneca, BMS, MSD, Novartis, Pfizer, Daiichi-Sankyo, Servier, CRAM, AFSSAPS, ARH Région de Bourgogne Clos.
Dallas 2015 TFQO: Karen Woolfrey #COI 261 EVREV 1: Karen Woolfrey # COI 261 EVREV 2: Daniel Pichel #COI 513 Taskforce: ACS ACS 872: Pre-hospital Diversion.
Transfers, Facilitated and Rescue PCI for AMI Michael J Cowley, M.D., FSCAI Nothing to disclose.
High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.
SPEED : GUSTO-IV PILOT GUSTO-IV Pilot Trial. SPEED : GUSTO-IV PILOT Rationale for Combination Therapy in AMI Enhance Incidence and Speed of Reperfusion.
Heparin Should be the First-line Therapy for Patients with ACS/AMI
Prof Kim Myeong Kon / R1 Park Ji Yoon
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
European Heart Association Journal 2007 April
% Heparin + GPI IIb/IIIa Bivalirudin +
Mancini JG, et al. Am J Cardiol.
ACC/SCAI – i2 Summit Late Breaking Clinical Trials March 29, 2008
Circulation 2001;104: Circulation 2001;104:
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
Management of AMI in patients presenting with STEMI
16-year follow-up of the DANish Acute Myocardial Infarction 2 (DANAMI-2) trial PG Thranea, SD Kristensena, KKW Olesena, LS Mortensenb, HE Bøtkera, L.
Presentation transcript:

Advanced Cardiovascular Intervention 2009 Timings in PPCI: Have we learnt the lessons from our European Colleagues? Peter F Ludman

Europe

Denmark DANAMI

Denmark Netherlands Amsterdam Zwolle

Denmark Netherlands Germany Schomig Kastrati

Denmark Netherlands Germany Czech PRAGUE 1 and 2

Denmark Netherlands Germany Czech Poland

Denmark Netherlands Germany Czech Poland France CAPTIM

Denmark Netherlands Germany Czech Poland France Italy

Denmark Netherlands Germany Czech Poland France Italy Spain

Denmark Netherlands Germany Czech Poland France Italy Spain Sweden

Denmark Netherlands Germany Czech Poland France Italy Spain Austria (Vienna) Sweden

Timings in PPCI Patient delay EMS delay 15 minDTBTransport to PCI centre Onset of STEMI FMC Reperfusion

Timings in PPCI Patient delay EMS delay EMS arrival to needle (30 min) Patient delay EMS delay 15 minDTBTransport to PCI centre PCI Related Delay Onset of STEMI FMC Reperfusion

Timings in PPCI Patient delay EMS delay EMS arrival to needle (30 min) Patient delay EMS delay 15 minDTBTransport to PCI centre PCI Related Delay Onset of STEMI FMC Reperfusion

Timings in PPCI Patient delay EMS delay EMS arrival to needle (30 min) Patient delay EMS delay 15 minDTBTransport to PCI centre PCI Related Delay Onset of STEMI FMC Reperfusion

Published data point

Meta analysis (published data)

PCI Related Delay Nallamothu AJC 2003;92:824– min

Errors PCI Related Delay Nallamothu AJC 2003;92:824–826 Nallamothu Am J Cardiol 2004;94:772–4 Betriu A, Masotti M Am J Cardiol 2005;95:100 Asseburg Heart 2007;93:1244–50 Terkelsen Heart

Prague-1 Prague-2 Veermer Danami-2 Garcia Ribicini Gibbons

Prague-1 Prague-2 Veermer Danami-2 Garcia Ribicini Gibbons

Prague-1 Prague-2 Veermer Danami-2 Garcia Ribicini Gibbons Terkelsen

PCI Related Delay Terkelsen Heart p=0.6

t = 171 min PCI Related Delay Terkelsen Heart p=0.6

PCI Related Delay Terkelsen Heart AllAll, Danami split FSFS, Danami split

Meta analysis (published data)

Patient level meta-analysis

PCI Related Delay Boersma EHJ

PCI Related Delay Patient delay EMS delay EMS arrival to needle (30 min) on scene delay Patient delay EMS delay 15 minDTB (30 min) Maximum acceptable transport time (105 min) PCI Related Delay

PCI Related Delay Patient delay EMS delay EMS arrival to needle (30 min) on scene delay Patient delay EMS delay 15 minDTB (30 min) Maximum acceptable transport time (105 min) PCI Related Delay

But..... PCI –40% stents –<30% GP IIb/IIIa blockers –Clopidogrel dosing –No Prasugrel Lytic –No mandated cath / PCI –Little rescue

Timings in PPCI Patient delay EMS delay EMS arrival to needle (30 min) Patient delay EMS delay 15 minDTBTransport to PCI centre PCI Related Delay Onset of STEMI FMC Reperfusion

Time Delays v Observed Mortality Zijlstra EHJ 2002:23;550 % Mortality Lysis PPCI

Time Delays v Observed Mortality Zijlstra EHJ 2002:23;550 % Mortality Lysis PPCI No rush if doing PPCI?

Observed Outcome v Delay GRACE registry Lysis PPCI

Observed mortality Vienna STEMI registry, Kalla Circulation 2006;113;2398

The Impossible Trial

Randomise to delay of: 0 to 120 min

Randomise to delay of: 0 to 120 min Start PPCI / Lytic

PCI Related Delay Time delay to presentation / Rx Mortality %

PCI Related Delay Time delay to presentation / Rx Mortality % PPCI relatively time independent ONLY If all patients present with same pre Rx risk

PCI Related Delay Mortality % Time delay to presentation / Rx

PCI Related Delay Mortality % Time delay to presentation / Rx Early presenters High risk Late presenters Low risk

PCI Related Delay Terkelsen Heart Time delay to presentation / Rx Mortality % Benefit from PPCI

What are the lessons? PPCI preferred to lysis in almost all settings Time matters –Rx a quick as possible –Networks of care required –Paramedic diagnosis + drive to PPCI (? 100 min drive time) Significant uncertainty about details!

Have we learnt the lessons? PPCI is becoming the dominant strategy

IHT causes delay NIAP and Provisional analysis of BCIS data

IHT causes delay NIAP and Provisional analysis of BCIS data

PPCI for STEMI Admission route % of patients admitted direct to PCI centre

Conclusions lessons –PPCI dominant strategy –Speed matters Suggested  delay dependency of PPCI misleading Public awareness campaigns Networks –Pre hospital diagnosis –Avoid IHT if possible –‘PCI related delay’ Uncertain Varies with clinical presentation

The End

ESC Guidelines EHJ 2008;29:2909

PCI related delay Pinto Circulation 2006;114:2019

PCI related delay NRMI database –PCI related delay v Mortality by subset Pinto Circulation 2006;114:2019

PCI related delay NRMI database –PCI related delay v Mortality by subset Pinto Circulation 2006;114:2019 Younger, Anterior MI need quicker PPCI

PCI related delay Tarantini EHJ 2009 Nov (ahead of print) Reduction in Mortality by PPCI (over lysis) = x PPCI Delay 0.59 x Pre Rx Mortality Risk x Presentation Delay - - +

PCI related delay Tarantini EHJ 2009 Nov (ahead of pub)

PCI related delay Tarantini EHJ 2009 Nov (ahead of pub)